Literature DB >> 7611484

Continuous, on-line, real-time spectral analysis of SAP signals during cardiopulmonary bypass.

M W Yang1, T B Kuo, S M Lin, K H Chan, S H Chan.   

Abstract

We communicated the application of continuous, on-line, real-time power spectral analysis of systemic arterial pressure (SAP) signals during cardiopulmonary bypass when the heart was functionally but reversibly disconnected from the blood vessels. Based on observations from 15 cases of successfully completed coronary artery bypass grafting procedures, we found that the very low (0.00-0.08 Hz), low (0.08-0.15 Hz)-, high (0.15-0.25 Hz)-, and very high (0.80-1.60 Hz) frequency components of SAP signals exhibited differential changes before, during, and after cardiopulmonary bypass. In particular, the very low-frequency component, which purportedly represents the contribution of vasomotor activity to SAP, presented only a mild decrease in power during hypothermic cardioplegia. Interestingly, the total peripheral resistance also manifested only a slight reduction during the same period. On the other hand, the low-, high-, and very high frequency components were essentially eliminated. These results unveiled an active role for the blood vessels in the maintenance of SAP during cardiopulmonary bypass, possibly as a result of a maintained vasomotor tone as reflected by the sustained very low frequency component of the SAP signals.

Entities:  

Mesh:

Year:  1995        PMID: 7611484     DOI: 10.1152/ajpheart.1995.268.6.H2329

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Detection of very low-frequency oscillations of cerebral haemodynamics is influenced by data detrending.

Authors:  T Müller; M Reinhard; E Oehm; A Hetzel; J Timmer
Journal:  Med Biol Eng Comput       Date:  2003-01       Impact factor: 2.602

2.  Brain stem death as the vital determinant for resumption of spontaneous circulation after cardiac arrest in rats.

Authors:  Alice Y W Chang; Julie Y H Chan; Yao-Chung Chuang; Samuel H H Chan
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.